Health & Fitness | Vaccine information

Texas Tech Health Sciences Center Researcher Receives NIH Grant for Vaccine

The three-year NIAID/SBIR-R44 Phase II Grant is to prepare the Schistosomiasis Vaccine (SchistoShield®) for human clinical trials

This is excellent for Texas Tech and for DrSiddiqui. This is where vaccine research and development SHOULD be. NOT for something like chicken pox.

Now, can we do this without aborted fetal lines?